Sunday, April 02, 2017 1:03:04 AM
biosectinvestor,
Law and process is not the issue for me. The subjectivity of law and process enforcement due to access to financial renumeration and influential interpersonal connections rather than set impartial boundaries to limit such subjectivity created by these influences is troubling. Knowing that our legal system and tax code could be made better but are not because of damaging entrenched interests that are experts in law and influence peddling is very problematic. Thomas Jefferson was right, there needs to be a kind of revolution from the people against the entrenched interests every once in a while to shake things up and keep those entrusted with making and keeping the laws honest and not so complacent. The status quo becomes subject to change when enough people are hurt by it. NWBO does not represent the status quo and I am anxious to see how these final battles play out because I see how they can be the impetus for a great deal of change beyond just cancer treatment. Best wishes.
Law and process is not the issue for me. The subjectivity of law and process enforcement due to access to financial renumeration and influential interpersonal connections rather than set impartial boundaries to limit such subjectivity created by these influences is troubling. Knowing that our legal system and tax code could be made better but are not because of damaging entrenched interests that are experts in law and influence peddling is very problematic. Thomas Jefferson was right, there needs to be a kind of revolution from the people against the entrenched interests every once in a while to shake things up and keep those entrusted with making and keeping the laws honest and not so complacent. The status quo becomes subject to change when enough people are hurt by it. NWBO does not represent the status quo and I am anxious to see how these final battles play out because I see how they can be the impetus for a great deal of change beyond just cancer treatment. Best wishes.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
